Acute lymphoblastic leukaemia
F Malard, M Mohty - The Lancet, 2020 - thelancet.com
Acute lymphoblastic leukaemia develops in both children and adults, with a peak incidence
between 1 year and 4 years. Most acute lymphoblastic leukaemia arises in healthy …
between 1 year and 4 years. Most acute lymphoblastic leukaemia arises in healthy …
Acute lymphoblastic leukemia in children
SP Hunger, CG Mullighan - New England Journal of Medicine, 2015 - Mass Medical Soc
Acute Lymphoblastic Leukemia in Children | New England Journal of Medicine Skip to main
content The New England Journal of Medicine homepage Advanced Search SEARCH …
content The New England Journal of Medicine homepage Advanced Search SEARCH …
Blinatumomab for MRD-negative acute lymphoblastic leukemia in adults
MR Litzow, Z Sun, RJ Mattison… - … England Journal of …, 2024 - Mass Medical Soc
Background Many older adults with B-cell precursor acute lymphoblastic leukemia (BCP-
ALL) have a relapse despite having a measurable residual disease (MRD)–negative …
ALL) have a relapse despite having a measurable residual disease (MRD)–negative …
Acute lymphoblastic leukemia, version 2.2021, NCCN clinical practice guidelines in oncology
PA Brown, B Shah, A Advani, P Aoun… - Journal of the National …, 2021 - jnccn.org
The NCCN Guidelines for Acute Lymphoblastic Leukemia (ALL) focus on the classification of
ALL subtypes based on immunophenotype and cytogenetic/molecular markers; risk …
ALL subtypes based on immunophenotype and cytogenetic/molecular markers; risk …
A pediatric regimen for older adolescents and young adults with acute lymphoblastic leukemia: results of CALGB 10403
Retrospective studies have suggested that older adolescents and young adults (AYAs) with
acute lymphoblastic leukemia (ALL) have better survival rates when treated using a pediatric …
acute lymphoblastic leukemia (ALL) have better survival rates when treated using a pediatric …
Cancer treatment and survivorship statistics, 2022
The number of cancer survivors continues to increase in the United States due to the growth
and aging of the population as well as advances in early detection and treatment. To assist …
and aging of the population as well as advances in early detection and treatment. To assist …
Adolescent and young adult (AYA) oncology, version 2.2024, NCCN clinical practice guidelines in oncology
S Bhatia, AS Pappo, M Acquazzino… - Journal of the National …, 2023 - jnccn.org
This selection from the NCCN Guidelines for Adolescent and Young Adult (AYA) Oncology
focuses on considerations for the comprehensive care of AYA patients with cancer …
focuses on considerations for the comprehensive care of AYA patients with cancer …
Role of clinical trial participation in cancer research: barriers, evidence, and strategies
JM Unger, E Cook, E Tai… - American Society of …, 2016 - pmc.ncbi.nlm.nih.gov
OVERVIEW Fewer than 1 in 20 adult cancer patients enroll in cancer clinical trials. But
although barriers to trial participation have been the subject of frequent study, the rate of trial …
although barriers to trial participation have been the subject of frequent study, the rate of trial …
Results of NOPHO ALL2008 treatment for patients aged 1–45 years with acute lymphoblastic leukemia
N Toft, H Birgens, J Abrahamsson, L Griškevičius… - Leukemia, 2018 - nature.com
Adults with acute lymphoblastic leukemia (ALL) do worse than children. From 7/2008 to
12/2014, Nordic and Baltic centers treated 1509 consecutive patients aged 1–45 years with …
12/2014, Nordic and Baltic centers treated 1509 consecutive patients aged 1–45 years with …
Evolving therapy of adult acute lymphoblastic leukemia: state-of-the-art treatment and future directions
B Samra, E Jabbour, F Ravandi, H Kantarjian… - Journal of hematology & …, 2020 - Springer
Recent years have witnessed major advances that have improved outcome of adults with
acute lymphoblastic leukemia (ALL). The emergence of the concept of measurable residual …
acute lymphoblastic leukemia (ALL). The emergence of the concept of measurable residual …